fda crackdown on compounded semaglutide is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Semaglutide
Description
Around 4.9 million adults in Britain nearly one in 10 have already used or are considering weight-loss drugs, says Ali Morpeth, co-founder of the Planeatry Alliance

FAQ What is a 503A versus a 503B compounding pharmacy

Every time you skip a dose, your body needs time to readjust

That's the concern published research has been building a case around for the past two years, and it's exactly the gap GLP BodyGuard is built to address

For now, clinicians should continue to rely on established depression treatments while monitoring ongoing research in this evolving field.

We start most patients on Semaglutide and, when it makes sense, upgrade to Tirzepatide based on your progress and how your body responds
